Drug Interaction Between Eperisone and Pregabalin

Pharmacological Basis for Lack of Interaction

Eperisone is a centrally-acting muscle relaxant with minimal available interaction data in the provided evidence 1

Monitor for additive CNS depression when combining pregabalin with any CNS-active medication, including muscle relaxants 2
Pregabalin commonly causes dizziness (23-46%), somnolence (15-25%), and peripheral edema (10%) in a dose-dependent manner 3
When combining pregabalin with other medications, monitor specifically for increased sedation, dizziness, and cognitive impairment 2

Start with standard pregabalin dosing (75 mg twice daily or 50 mg three times daily) as no dose adjustment is required for this combination 3, 2
Implement gradual titration to minimize side effects, particularly in elderly patients 3
Counsel patients specifically about potential increased drowsiness, dizziness, and impaired coordination when starting combination therapy 2
No specific laboratory monitoring is required beyond standard clinical assessment for each medication individually 4

Consider lower starting doses of pregabalin (50 mg twice daily) and slower titration due to increased risk of falls, confusion, and sedation in elderly patients 1, 3
Elderly patients are more susceptible to CNS side effects from both medications 1

Mandatory dose reduction of pregabalin in patients with reduced renal function: reduce total daily dose by approximately 50% for CrCl 30-60 mL/min, 75% for CrCl 15-30 mL/min, and 85-90% for CrCl <15 mL/min 3

Do not withhold either medication based on theoretical concerns when both are clinically indicated 4
Do not fail to warn patients about additive sedation risk, particularly when driving or operating machinery 2
Avoid combining with additional CNS depressants (opioids, benzodiazepines) without careful monitoring, as pregabalin carries warnings about serious breathing problems with such combinations 3